PETMED EXPRESS INC
About PETMED EXPRESS INC
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2026
- $179.0M
- Net income
- -$57.3M
- Total assets
- $81.2M
- Market cap
- $35.9M
- Gross margin
- 28.1%
- Operating margin
- -32.8%
- Net margin
- -32.0%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $179.0M
- Cost of revenue
- $128.8M
- Gross profit
- $50.2M
- Operating expenses
- $108.9M
- Operating income
- -$58.7M
- Income tax
- -$73.0K
- Net income
- -$57.3M
- EPS (basic)
- $-2.74
- EPS (diluted)
- $-2.74
Balance sheet
- Total assets
- $81.2M
- Current assets
- $43.6M
- Total liabilities
- $52.3M
- Current liabilities
- $52.0M
- Shareholders’ equity
- $28.9M
Cash flow
- Operating cash flow
- -$28.4M
- Investing cash flow
- -$4.6M
- Financing cash flow
- -$299.0K
- Net cash flow
- -$33.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $35.9M
- EPS (diluted)
- $-2.74
- Dividend yield
- 70.59%
- Shares outstanding
- 21.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 17, 1997
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $57.3M in FY2026.
- Revenue declined 35% from FY2022 to FY2026.
- Gross margin of 28.1%, net margin -32.0%.
- Trading 59% below its 52-week high.
- Pays a dividend yielding about 70.59% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review PETMED EXPRESS INC.
Write a review
News about PETMED EXPRESS INC
News & sentiment via Polygon.io
